Cryo-Cell CCEL Stock
Cryo-Cell Price Chart
Cryo-Cell CCEL Financial and Trading Overview
Cryo-Cell stock price | 6.33 USD |
Previous Close | 5.34 USD |
Open | 6.03 USD |
Bid | 2.3 USD x 800 |
Ask | 0 USD x 800 |
Day's Range | 5.41 - 6.03 USD |
52 Week Range | 2.69 - 8.12 USD |
Volume | 7.8K USD |
Avg. Volume | 9.1K USD |
Market Cap | 49.82M USD |
Beta (5Y Monthly) | 0.323591 |
PE Ratio (TTM) | 20 |
EPS (TTM) | 0.05 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | September 1, 2022 |
1y Target Est | 10 USD |
CCEL Valuation Measures
Enterprise Value | 53.14M USD |
Trailing P/E | 20 |
Forward P/E | 40 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.6122122 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 1.72 |
Enterprise Value/EBITDA | 8.715 |
Trading Information
Cryo-Cell Stock Price History
Beta (5Y Monthly) | 0.323591 |
52-Week Change | 2.04% |
S&P500 52-Week Change | 20.43% |
52 Week High | 8.12 USD |
52 Week Low | 2.69 USD |
50-Day Moving Average | 4.64 USD |
200-Day Moving Average | 4.69 USD |
CCEL Share Statistics
Avg. Volume (3 month) | 9.1K USD |
Avg. Daily Volume (10-Days) | 10.1K USD |
Shares Outstanding | 8.3M |
Float | 4.48M |
Short Ratio | 2.5 |
% Held by Insiders | 47.58% |
% Held by Institutions | 12.58% |
Shares Short | 17.36K |
Short % of Float | 0.30% |
Short % of Shares Outstanding | 0.20% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | November 30, 2022 |
Most Recent Quarter (mrq) | February 28, 2023 |
Next Fiscal Year End | November 30, 2023 |
Profitability
Profit Margin | 8.75% |
Operating Margin (ttm) | 14.96% |
Gross Margin | 71.66% |
EBITDA Margin | 19.73% |
Management Effectiveness
Return on Assets (ttm) | 4.77% |
Return on Equity (ttm) | 151.87% |
Income Statement
Revenue (ttm) | 30.9M USD |
Revenue Per Share (ttm) | 3.66 USD |
Quarterly Revenue Growth (yoy) | 7.79% |
Gross Profit (ttm) | 21.54M USD |
EBITDA | 6.1M USD |
Net Income Avi to Common (ttm) | 2.71M USD |
Diluted EPS (ttm) | 0.3 |
Quarterly Earnings Growth (yoy) | -7.79% |
Balance Sheet
Total Cash (mrq) | 2.21M USD |
Total Cash Per Share (mrq) | 0.27 USD |
Total Debt (mrq) | 11.01M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.562 |
Book Value Per Share (mrq) | -0.081 |
Cash Flow Statement
Operating Cash Flow (ttm) | 8.71M USD |
Levered Free Cash Flow (ttm) | -6808467 USD |
Profile of Cryo-Cell
Country | United States |
State | FL |
City | Oldsmar |
Address | 700 Brooker Creek Boulevard |
ZIP | 34677 |
Phone | 813 749 2100 |
Website | https://www.cryo-cell.com |
Industry | Medical Care Facilities |
Sector(s) | Healthcare |
Full Time Employees | 80 |
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Q&A For Cryo-Cell Stock
What is a current CCEL stock price?
Cryo-Cell CCEL stock price today per share is 6.33 USD.
How to purchase Cryo-Cell stock?
You can buy CCEL shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cryo-Cell?
The stock symbol or ticker of Cryo-Cell is CCEL.
Which industry does the Cryo-Cell company belong to?
The Cryo-Cell industry is Medical Care Facilities.
How many shares does Cryo-Cell have in circulation?
The max supply of Cryo-Cell shares is 8.08M.
What is Cryo-Cell Price to Earnings Ratio (PE Ratio)?
Cryo-Cell PE Ratio is 126.60000000 now.
What was Cryo-Cell earnings per share over the trailing 12 months (TTM)?
Cryo-Cell EPS is 0.05 USD over the trailing 12 months.
Which sector does the Cryo-Cell company belong to?
The Cryo-Cell sector is Healthcare.